Search

You searched for "OCT"

2159 results found
Progress in Retinal and Eye Research.

The compendium to clinical evidence in DMO treatment

3 April 2024 | | EYE - Vitreo-Retinal
This review article summarises the current evidence base in the treatment options for diabetic macular oedema (DMO). The authors have included many real-world data studies that provided valuable insights into the optimal management of DMO. The authors argue that these...
Journal of Pediatric Ophthalmology & Strabismus cover image.

RCT of unilateral vs bilateral surgery for lateral incomitance in exotropia

29 March 2024 | | EYE - Paediatrics, EYE - Strabismus
The purpose of this study was to evaluate and compare the surgical outcomes in the management of lateral incomitance with regard to ocular alignment and change in lateral incomitance in cases of bilateral vs. unilateral strabismus surgery. This was a...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

An optometrist’s view of the Emergency Eye Day

1 October 2017 | | EYE - General
Liverpool is steeped in history, from its mercantile history, home to Cunard and the White Star line, to the Merseybeat and Derek Hatton. Not to be outdone at their annual meeting in the city, the Royal College of Ophthalmologists made...

Non-organic visual loss

2 December 2019 | | EYE - Neuro-ophthalmology, EYE - General
Patients can present to eye departments with various signs and symptoms (mostly symptoms) with no obvious organic cause. These patients can be labelled with any of a wide range of diagnoses such as functional visual loss, functional overlay, psychosomatic reaction...

Getting started in ophthalmology: Advice for new doctors

18 February 2026 | | EYE - General
Starting your first rotation in ophthalmology is exciting and a little daunting. As the start date approaches, the nerves may start to creep in. What’s expected of me? How much ophthalmology am I supposed to know? How will the on-calls...

Developing community eye care: the GOS package in Scotland

1 December 2018 | | EYE - General
In the second in the series about community eye care in the home nations, Janet Pooley explains how Scotland has developed its services within GOS. The United Kingdom has devolved healthcare; the powers were transferred from Westminster to Scotland and...

“Beware of the pigment”

4 August 2021 | | EYE - Glaucoma, EYE - General
Using some captivating artwork, Iheukwumere Duru describes key features of pigment dispersion syndrome. Pigmentary dispersion syndrome (PDS) leads to pigmentary glaucoma (PG) in approximately 35-50% of patients with the condition [1]. PG is the leading cause of non-traumatic blindness in...

Designing ophthalmology services - Part 1: How do we address the queues in a clinic?

23 January 2020 | | EYE - General
This first of a three-part series shows how systems engineering can be used to correctly diagnose and address the causes of delays in a clinic. The second article, which will be featured in the April/May 2020 issue, describes how to...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Uveal melanoma

3 August 2023 | | EYE - Pathology, EYE - Oncology, EYE - Imaging
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...